38 related articles for article (PubMed ID: 23675653)
1. The Functional and Antiviral Activity of Interferon Alpha-Inducible IFI6 Against Hepatitis B Virus Replication and Gene Expression.
Sajid M; Ullah H; Yan K; He M; Feng J; Shereen MA; Hao R; Li Q; Guo D; Chen Y; Zhou L
Front Immunol; 2021; 12():634937. PubMed ID: 33868257
[TBL] [Abstract][Full Text] [Related]
2. Autophagy-related protein 5 (ATG5) interacts with bone marrow stromal cell antigen 2 (BST2) to stimulate HBV replication through antagonizing the antiviral activity of BST2.
Li Q; Wen W; Wang Y; Gong T; Wang X; Tan Q; Fan B; Xie H; Li Y; Li S; Yang C; Zhou Z; Duan X; Lin W; Chen L
J Med Virol; 2024 May; 96(5):e29659. PubMed ID: 38747016
[TBL] [Abstract][Full Text] [Related]
3. Glucose-regulated protein 78 is an intracellular antiviral factor against hepatitis B virus.
Ma Y; Yu J; Chan HL; Chen YC; Wang H; Chen Y; Chan CY; Go MY; Tsai SN; Ngai SM; To KF; Tong JH; He QY; Sung JJ; Kung HF; Cheng CH; He ML
Mol Cell Proteomics; 2009 Nov; 8(11):2582-94. PubMed ID: 19671925
[TBL] [Abstract][Full Text] [Related]
4. A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor.
Eller C; Heydmann L; Colpitts CC; El Saghire H; Piccioni F; Jühling F; Majzoub K; Pons C; Bach C; Lucifora J; Lupberger J; Nassal M; Cowley GS; Fujiwara N; Hsieh SY; Hoshida Y; Felli E; Pessaux P; Sureau C; Schuster C; Root DE; Verrier ER; Baumert TF
Nat Commun; 2020 Jun; 11(1):2707. PubMed ID: 32483149
[TBL] [Abstract][Full Text] [Related]
5. Increased GABA signaling in liver macrophage promotes HBV replication in HBV-carrier mice.
Chen Y; Yin Z; Zhang X; Zhao Y; Liu T; Lu WY; Wang S
Virus Res; 2024 Jun; 344():199366. PubMed ID: 38548137
[TBL] [Abstract][Full Text] [Related]
6. Research Advances on the Role of Lipids in the Life Cycle of Human Coronaviruses.
Ding C; Chen Y; Miao G; Qi Z
Microorganisms; 2023 Dec; 12(1):. PubMed ID: 38257890
[TBL] [Abstract][Full Text] [Related]
7. SCD1 inhibits HBV replication by regulating autophagy under high lipid conditions.
Du X; Shi X; Han M; Gao X; Wang C; Jiang C; Pu C
Virus Genes; 2023 Dec; 59(6):801-816. PubMed ID: 37644346
[TBL] [Abstract][Full Text] [Related]
8. Circulating soluble CD36 as a novel biomarker for progression and prognosis of HBV-related liver diseases.
Cai C; Xiao A; Luo X; Zheng E; Li Y; Lei Y; Zhong S; Chen Y; Yang P; Tang Z; Zhou Z
Front Microbiol; 2022; 13():1039614. PubMed ID: 36406414
[TBL] [Abstract][Full Text] [Related]
9. Multifaceted Interaction Between Hepatitis B Virus Infection and Lipid Metabolism in Hepatocytes: A Potential Target of Antiviral Therapy for Chronic Hepatitis B.
Zhang J; Ling N; Lei Y; Peng M; Hu P; Chen M
Front Microbiol; 2021; 12():636897. PubMed ID: 33776969
[TBL] [Abstract][Full Text] [Related]
10. Effect of haptoglobin on the treatment of chronic hepatitis B with interferon.
Lv LL; Yang YX; Shi TD
Exp Ther Med; 2019 Aug; 18(2):1417-1425. PubMed ID: 31316628
[TBL] [Abstract][Full Text] [Related]
11. Differentially expressed proteins underlying childhood cortical dysplasia with epilepsy identified by iTRAQ proteomic profiling.
Qin L; Liu X; Liu S; Liu Y; Yang Y; Yang H; Chen Y; Chen L
PLoS One; 2017; 12(2):e0172214. PubMed ID: 28222113
[TBL] [Abstract][Full Text] [Related]
12. LHBs can elevate the expression of MDR1 through HIF-1α in patients with CHB infection: a comparative proteomic study.
Li S; Yang Y; Ding X; Yang M; She S; Peng H; Xu X; Ran X; Li S; Hu P; Hu H; Zhang D; Ren H
Oncotarget; 2017 Jan; 8(3):4549-4562. PubMed ID: 27999186
[TBL] [Abstract][Full Text] [Related]
13. Covariation Analysis of Serumal and Urinary Metabolites Suggests Aberrant Glycine and Fatty Acid Metabolism in Chronic Hepatitis B.
Yang L; Yang X; Kong X; Cao Z; Zhang Y; Hu Y; Tang K
PLoS One; 2016; 11(5):e0156166. PubMed ID: 27228119
[TBL] [Abstract][Full Text] [Related]
14. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
Ohol YM; Wang Z; Kemble G; Duke G
PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
[TBL] [Abstract][Full Text] [Related]
15. The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment.
Li H; Zhu W; Zhang L; Lei H; Wu X; Guo L; Chen X; Wang Y; Tang H
Sci Rep; 2015 Feb; 5():8421. PubMed ID: 25672227
[TBL] [Abstract][Full Text] [Related]
16. Liver cancer-related gene CYP2E1 expression in HBV transgenic mice with acute liver injury.
Zhang C; Wei Q; Jiang T; Shou X; Li ZQ; Wen H
Tumour Biol; 2014 Apr; 35(4):3671-7. PubMed ID: 24318994
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of host genes including hepatic fatty acid synthase in HBV-transgenic mice.
Zhang H; Li H; Yang Y; Li S; Ren H; Zhang D; Hu H
J Proteome Res; 2013 Jun; 12(6):2967-79. PubMed ID: 23675653
[TBL] [Abstract][Full Text] [Related]
18. HSPB1 is an intracellular antiviral factor against hepatitis B virus.
Tong SW; Yang YX; Hu HD; An X; Ye F; Ren H; Li SL; Zhang DZ
J Cell Biochem; 2013 Jan; 114(1):162-73. PubMed ID: 22887120
[TBL] [Abstract][Full Text] [Related]
19. Hepatocytes proteomic alteration and seroproteome analysis of HBV-transgenic mice.
Ding C; Wei H; Sun R; Zhang J; Tian Z
Proteomics; 2009 Jan; 9(1):87-105. PubMed ID: 19053081
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
